Mylan Current Ratio 2006-2018 | MYL

Current and historical current ratio for Mylan (MYL) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Mylan current ratio for the three months ending September 30, 2018 was 1.26.
Mylan Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $6.54B $5.18B 1.26
2018-06-30 $6.30B $4.86B 1.30
2018-03-31 $6.76B $6.39B 1.06
2017-12-31 $7.21B $6.39B 1.13
2017-09-30 $7.27B $4.98B 1.46
2017-06-30 $6.97B $5.17B 1.35
2017-03-31 $7.07B $4.52B 1.56
2016-12-31 $7.52B $5.04B 1.49
2016-09-30 $7.97B $9.55B 0.83
2016-06-30 $12.19B $3.78B 3.23
2016-03-31 $6.63B $3.96B 1.67
2015-12-31 $6.47B $4.12B 1.57
2015-09-30 $6.49B $3.68B 1.76
2015-06-30 $7.89B $5.37B 1.47
2015-03-31 $7.43B $5.29B 1.40
2014-12-31 $6.44B $5.30B 1.21
2014-09-30 $5.82B $4.47B 1.30
2014-06-30 $4.48B $2.60B 1.72
2014-03-31 $4.34B $2.65B 1.64
2013-12-31 $4.47B $2.96B 1.51
2013-09-30 $4.34B $2.56B 1.70
2013-06-30 $4.21B $2.33B 1.81
2013-03-31 $3.95B $2.28B 1.73
2012-12-31 $3.90B $2.19B 1.78
2012-09-30 $3.75B $2.17B 1.73
2012-06-30 $3.75B $2.16B 1.73
2012-03-31 $3.74B $2.11B 1.77
2011-12-31 $3.57B $2.56B 1.39
2011-09-30 $3.61B $2.38B 1.52
2011-06-30 $3.76B $2.52B 1.49
2011-03-31 $3.76B $2.39B 1.57
2010-12-31 $3.56B $1.81B 1.97
2010-09-30 $3.46B $1.72B 2.01
2010-06-30 $3.63B $1.63B 2.23
2010-03-31 $3.36B $1.64B 2.05
2009-12-31 $3.29B $1.72B 1.91
2009-09-30 $3.26B $1.58B 2.06
2009-06-30 $3.02B $1.42B 2.13
2009-03-31 $2.91B $1.34B 2.17
2008-12-31 $3.18B $1.55B 2.06
2008-09-30 $3.42B $1.82B 1.88
2008-06-30 $3.48B $2.11B 1.65
2008-03-31 $3.49B $2.22B 1.57
2007-12-31 $3.06B $2.00B 1.53
2007-09-30 $2.62B $0.77B 3.42
2007-06-30 $2.62B $0.83B 3.16
2007-03-31 $2.41B $0.70B 3.44
2006-12-31 $1.28B $0.29B 4.46
2006-09-30 $1.33B $0.26B 5.13
2006-06-30 $1.29B $0.29B 4.41
2006-03-31 $1.19B $0.27B 4.49
2005-12-31 $1.17B $0.26B 4.45
2005-09-30 $1.27B $0.27B 4.70
2005-06-30 $1.57B $0.26B 5.93
2005-03-31 $1.53B $0.25B 6.23
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $19.053B $11.908B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $55.828B 9.58
Teva Pharmaceutical Industries (TEVA) Israel $23.846B 7.31
Bausch Health Cos (BHC) Canada $9.511B 6.89
Dr Reddy's Laboratories (RDY) India $5.520B 22.05
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.574B 4.29
Supernus Pharmaceuticals (SUPN) United States $2.364B 22.41
Amphastar Pharmaceuticals (AMPH) United States $0.999B 107.95
Akorn (AKRX) United States $0.860B 0.00
Homology Medicines (FIXX) United States $0.755B 0.00
CymaBay Therapeutics (CBAY) United States $0.687B 0.00
Assembly Biosciences (ASMB) United States $0.596B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.457B 0.00
Corium (CORI) United States $0.457B 0.00
Voyager Therapeutics (VYGR) United States $0.401B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.325B 0.00
Teligent (TLGT) United States $0.174B 0.00
Sol-Gel Technologies (SLGL) Israel $0.133B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.105B 0.00
Aevi Genomic Medicine (GNMX) United States $0.084B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.055B 0.00
Acasti Pharma (ACST) Canada $0.053B 0.00
Evoke Pharma (EVOK) United States $0.047B 0.00
Agile Therapeutics (AGRX) United States $0.034B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.010B 0.00